nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—ovarian cancer	0.759	1	CbGaD
Flupentixol—ABCB1—Topotecan—ovarian cancer	0.0703	0.354	CbGbCtD
Flupentixol—ABCB1—Vinorelbine—ovarian cancer	0.0495	0.249	CbGbCtD
Flupentixol—ABCB1—Paclitaxel—ovarian cancer	0.0348	0.175	CbGbCtD
Flupentixol—ABCB1—Docetaxel—ovarian cancer	0.0252	0.127	CbGbCtD
Flupentixol—ABCB1—Doxorubicin—ovarian cancer	0.0187	0.0945	CbGbCtD
Flupentixol—HTR2A—vein—ovarian cancer	0.0027	0.193	CbGeAlD
Flupentixol—DDC—embryo—ovarian cancer	0.00179	0.127	CbGeAlD
Flupentixol—DDC—female reproductive system—ovarian cancer	0.00108	0.0772	CbGeAlD
Flupentixol—DDC—testis—ovarian cancer	0.000874	0.0623	CbGeAlD
Flupentixol—ADRA1A—epithelium—ovarian cancer	0.000646	0.046	CbGeAlD
Flupentixol—DDC—lymph node—ovarian cancer	0.000634	0.0451	CbGeAlD
Flupentixol—CHRM1—female reproductive system—ovarian cancer	0.000584	0.0416	CbGeAlD
Flupentixol—HTR2A—embryo—ovarian cancer	0.000512	0.0365	CbGeAlD
Flupentixol—HTR2A—epithelium—ovarian cancer	0.000418	0.0297	CbGeAlD
Flupentixol—DRD2—testis—ovarian cancer	0.000379	0.027	CbGeAlD
Flupentixol—ABCB1—myometrium—ovarian cancer	0.000349	0.0248	CbGeAlD
Flupentixol—HTR2A—gonad—ovarian cancer	0.000347	0.0247	CbGeAlD
Flupentixol—ABCB1—embryo—ovarian cancer	0.000335	0.0239	CbGeAlD
Flupentixol—HTR2A—female reproductive system—ovarian cancer	0.00031	0.0221	CbGeAlD
Flupentixol—HTR2A—vagina—ovarian cancer	0.000281	0.02	CbGeAlD
Flupentixol—ABCB1—epithelium—ovarian cancer	0.000274	0.0195	CbGeAlD
Flupentixol—ABCB1—uterine cervix—ovarian cancer	0.000271	0.0193	CbGeAlD
Flupentixol—ABCB1—decidua—ovarian cancer	0.000258	0.0184	CbGeAlD
Flupentixol—HTR2A—testis—ovarian cancer	0.00025	0.0178	CbGeAlD
Flupentixol—ABCB1—endometrium—ovarian cancer	0.000245	0.0175	CbGeAlD
Flupentixol—ABCB1—gonad—ovarian cancer	0.000228	0.0162	CbGeAlD
Flupentixol—ABCB1—uterus—ovarian cancer	0.000226	0.0161	CbGeAlD
Flupentixol—ABCB1—female reproductive system—ovarian cancer	0.000203	0.0145	CbGeAlD
Flupentixol—ABCB1—bone marrow—ovarian cancer	0.000192	0.0137	CbGeAlD
Flupentixol—ABCB1—female gonad—ovarian cancer	0.000185	0.0132	CbGeAlD
Flupentixol—ABCB1—vagina—ovarian cancer	0.000184	0.0131	CbGeAlD
Flupentixol—ABCB1—testis—ovarian cancer	0.000164	0.0117	CbGeAlD
Flupentixol—ABCB1—lymph node—ovarian cancer	0.000119	0.00847	CbGeAlD
Flupentixol—DRD1—Signaling Pathways—CAV1—ovarian cancer	1.16e-05	0.000413	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PPP2R1A—ovarian cancer	1.15e-05	0.000409	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PIK3CD—ovarian cancer	1.14e-05	0.000407	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—PIK3CB—ovarian cancer	1.14e-05	0.000405	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PIK3CA—ovarian cancer	1.13e-05	0.000402	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—PIK3CB—ovarian cancer	1.12e-05	0.000399	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ESR1—ovarian cancer	1.12e-05	0.000398	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—PIK3CB—ovarian cancer	1.11e-05	0.000397	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL6ST—ovarian cancer	1.1e-05	0.000391	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—PIK3CB—ovarian cancer	1.1e-05	0.000391	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CXCL8—ovarian cancer	1.09e-05	0.00039	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—FASN—ovarian cancer	1.09e-05	0.000389	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CXCL8—ovarian cancer	1.08e-05	0.000383	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.07e-05	0.000382	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CXCL8—ovarian cancer	1.07e-05	0.000381	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—APC—ovarian cancer	1.06e-05	0.000376	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CG—ovarian cancer	1.06e-05	0.000376	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—NRAS—ovarian cancer	1.06e-05	0.000376	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CXCL8—ovarian cancer	1.05e-05	0.000375	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—IL2—ovarian cancer	1.05e-05	0.000372	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.04e-05	0.000369	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PIK3CB—ovarian cancer	1.03e-05	0.000368	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—IL2—ovarian cancer	1.03e-05	0.000366	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—IL2—ovarian cancer	1.02e-05	0.000364	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PIK3CB—ovarian cancer	1.02e-05	0.000362	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PIK3CB—ovarian cancer	1.01e-05	0.00036	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—MAPK3—ovarian cancer	1.01e-05	0.00036	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—IL2—ovarian cancer	1.01e-05	0.000359	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PIK3CB—ovarian cancer	9.96e-06	0.000355	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CYP1B1—ovarian cancer	9.94e-06	0.000354	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CXCL8—ovarian cancer	9.93e-06	0.000354	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CXCL8—ovarian cancer	9.78e-06	0.000348	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CXCL8—ovarian cancer	9.72e-06	0.000346	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—MAPK1—ovarian cancer	9.62e-06	0.000343	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—EGFR—ovarian cancer	9.62e-06	0.000342	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CXCL8—ovarian cancer	9.57e-06	0.000341	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL2—ovarian cancer	9.49e-06	0.000338	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TERT—ovarian cancer	9.46e-06	0.000337	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL2—ovarian cancer	9.34e-06	0.000333	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TERT—ovarian cancer	9.31e-06	0.000331	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL2—ovarian cancer	9.29e-06	0.000331	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CD—ovarian cancer	9.28e-06	0.00033	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TERT—ovarian cancer	9.26e-06	0.00033	CbGpPWpGaD
Flupentixol—DDC—Metabolism—AKT1—ovarian cancer	9.23e-06	0.000329	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—PIK3CA—ovarian cancer	9.19e-06	0.000327	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL2—ovarian cancer	9.15e-06	0.000326	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TERT—ovarian cancer	9.11e-06	0.000325	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—KRAS—ovarian cancer	9.09e-06	0.000324	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PPP2R1A—ovarian cancer	8.82e-06	0.000314	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CAV1—ovarian cancer	8.75e-06	0.000312	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CAV1—ovarian cancer	8.61e-06	0.000307	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CAV1—ovarian cancer	8.56e-06	0.000305	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ESR1—ovarian cancer	8.43e-06	0.0003	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CAV1—ovarian cancer	8.43e-06	0.0003	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PIK3CA—ovarian cancer	8.35e-06	0.000297	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ESR1—ovarian cancer	8.3e-06	0.000295	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL6ST—ovarian cancer	8.3e-06	0.000295	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ESR1—ovarian cancer	8.25e-06	0.000294	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ERBB2—ovarian cancer	8.2e-06	0.000292	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL6ST—ovarian cancer	8.16e-06	0.000291	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ESR1—ovarian cancer	8.12e-06	0.000289	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL6ST—ovarian cancer	8.12e-06	0.000289	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MTOR—ovarian cancer	8.09e-06	0.000288	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CB—ovarian cancer	8.09e-06	0.000288	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TYMS—ovarian cancer	8.04e-06	0.000286	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL6ST—ovarian cancer	7.99e-06	0.000285	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CG—ovarian cancer	7.97e-06	0.000284	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—APC—ovarian cancer	7.97e-06	0.000284	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—NRAS—ovarian cancer	7.97e-06	0.000284	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—APC—ovarian cancer	7.84e-06	0.000279	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CG—ovarian cancer	7.84e-06	0.000279	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—NRAS—ovarian cancer	7.84e-06	0.000279	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CG—ovarian cancer	7.8e-06	0.000278	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—APC—ovarian cancer	7.8e-06	0.000278	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—NRAS—ovarian cancer	7.8e-06	0.000278	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCL8—ovarian cancer	7.77e-06	0.000277	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HRAS—ovarian cancer	7.72e-06	0.000275	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—APC—ovarian cancer	7.68e-06	0.000273	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CG—ovarian cancer	7.68e-06	0.000273	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—NRAS—ovarian cancer	7.68e-06	0.000273	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—MAPK3—ovarian cancer	7.63e-06	0.000272	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CDKN1B—ovarian cancer	7.59e-06	0.00027	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—MAPK3—ovarian cancer	7.51e-06	0.000267	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AKT1—ovarian cancer	7.51e-06	0.000267	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—MAPK3—ovarian cancer	7.47e-06	0.000266	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CASP3—ovarian cancer	7.44e-06	0.000265	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL2—ovarian cancer	7.43e-06	0.000265	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—IL6—ovarian cancer	7.39e-06	0.000263	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—MAPK3—ovarian cancer	7.35e-06	0.000262	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—MAPK1—ovarian cancer	7.26e-06	0.000259	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—EGFR—ovarian cancer	7.26e-06	0.000259	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCND1—ovarian cancer	7.24e-06	0.000258	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CTNNB1—ovarian cancer	7.17e-06	0.000255	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—MAPK1—ovarian cancer	7.15e-06	0.000254	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—EGFR—ovarian cancer	7.15e-06	0.000254	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—MAPK1—ovarian cancer	7.11e-06	0.000253	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—EGFR—ovarian cancer	7.11e-06	0.000253	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MMP9—ovarian cancer	7.03e-06	0.00025	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CD—ovarian cancer	7.01e-06	0.00025	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—MAPK1—ovarian cancer	7e-06	0.000249	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—EGFR—ovarian cancer	7e-06	0.000249	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PTEN—ovarian cancer	6.99e-06	0.000249	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—PIK3CA—ovarian cancer	6.94e-06	0.000247	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CD—ovarian cancer	6.89e-06	0.000246	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—KRAS—ovarian cancer	6.86e-06	0.000244	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CD—ovarian cancer	6.86e-06	0.000244	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—PIK3CA—ovarian cancer	6.83e-06	0.000243	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AKT1—ovarian cancer	6.82e-06	0.000243	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	6.79e-06	0.000242	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CD—ovarian cancer	6.75e-06	0.00024	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—KRAS—ovarian cancer	6.75e-06	0.00024	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—KRAS—ovarian cancer	6.71e-06	0.000239	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—PIK3CA—ovarian cancer	6.69e-06	0.000238	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—KRAS—ovarian cancer	6.61e-06	0.000235	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CAV1—ovarian cancer	6.48e-06	0.000231	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VEGFA—ovarian cancer	6.31e-06	0.000225	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PIK3CA—ovarian cancer	6.3e-06	0.000224	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—STAT3—ovarian cancer	6.25e-06	0.000223	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NRAS—ovarian cancer	6.24e-06	0.000222	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PIK3CA—ovarian cancer	6.2e-06	0.000221	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ERBB2—ovarian cancer	6.19e-06	0.00022	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PIK3CA—ovarian cancer	6.17e-06	0.00022	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MTOR—ovarian cancer	6.11e-06	0.000217	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CB—ovarian cancer	6.11e-06	0.000217	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ERBB2—ovarian cancer	6.09e-06	0.000217	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PIK3CA—ovarian cancer	6.07e-06	0.000216	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ERBB2—ovarian cancer	6.06e-06	0.000216	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MTOR—ovarian cancer	6.01e-06	0.000214	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CB—ovarian cancer	6.01e-06	0.000214	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MTOR—ovarian cancer	5.98e-06	0.000213	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CB—ovarian cancer	5.98e-06	0.000213	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MAPK3—ovarian cancer	5.97e-06	0.000213	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ERBB2—ovarian cancer	5.96e-06	0.000212	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CG—ovarian cancer	5.9e-06	0.00021	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CB—ovarian cancer	5.88e-06	0.00021	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MTOR—ovarian cancer	5.88e-06	0.00021	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCL8—ovarian cancer	5.87e-06	0.000209	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HRAS—ovarian cancer	5.83e-06	0.000208	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MYC—ovarian cancer	5.81e-06	0.000207	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	5.77e-06	0.000206	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCL8—ovarian cancer	5.74e-06	0.000205	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	5.74e-06	0.000204	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	5.73e-06	0.000204	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HRAS—ovarian cancer	5.71e-06	0.000203	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MAPK1—ovarian cancer	5.68e-06	0.000202	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGFR—ovarian cancer	5.68e-06	0.000202	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	5.67e-06	0.000202	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	5.65e-06	0.000201	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	5.64e-06	0.000201	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	5.62e-06	0.0002	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CASP3—ovarian cancer	5.62e-06	0.0002	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CDKN1B—ovarian cancer	5.61e-06	0.0002	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL2—ovarian cancer	5.61e-06	0.0002	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL6—ovarian cancer	5.58e-06	0.000199	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	5.58e-06	0.000199	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AKT1—ovarian cancer	5.55e-06	0.000198	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CASP3—ovarian cancer	5.53e-06	0.000197	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	5.52e-06	0.000197	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL2—ovarian cancer	5.52e-06	0.000197	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CASP3—ovarian cancer	5.5e-06	0.000196	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL6—ovarian cancer	5.49e-06	0.000196	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL2—ovarian cancer	5.49e-06	0.000195	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCND1—ovarian cancer	5.47e-06	0.000195	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	5.46e-06	0.000195	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL6—ovarian cancer	5.46e-06	0.000194	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	5.41e-06	0.000193	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	5.41e-06	0.000193	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL2—ovarian cancer	5.4e-06	0.000192	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCND1—ovarian cancer	5.38e-06	0.000192	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	5.38e-06	0.000191	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—KRAS—ovarian cancer	5.37e-06	0.000191	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCND1—ovarian cancer	5.35e-06	0.000191	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	5.33e-06	0.00019	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MMP9—ovarian cancer	5.31e-06	0.000189	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CTNNB1—ovarian cancer	5.3e-06	0.000189	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PTEN—ovarian cancer	5.28e-06	0.000188	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	5.27e-06	0.000188	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MMP9—ovarian cancer	5.22e-06	0.000186	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	5.22e-06	0.000186	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MMP9—ovarian cancer	5.2e-06	0.000185	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PTEN—ovarian cancer	5.19e-06	0.000185	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CD—ovarian cancer	5.19e-06	0.000185	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PTEN—ovarian cancer	5.16e-06	0.000184	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AKT1—ovarian cancer	5.15e-06	0.000183	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	5.11e-06	0.000182	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	5.08e-06	0.000181	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	5.07e-06	0.00018	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	5.04e-06	0.000179	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	4.96e-06	0.000177	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	4.93e-06	0.000176	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—ovarian cancer	4.77e-06	0.00017	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VEGFA—ovarian cancer	4.77e-06	0.00017	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—STAT3—ovarian cancer	4.72e-06	0.000168	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NRAS—ovarian cancer	4.71e-06	0.000168	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	4.69e-06	0.000167	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	4.67e-06	0.000166	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—STAT3—ovarian cancer	4.64e-06	0.000165	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NRAS—ovarian cancer	4.63e-06	0.000165	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—STAT3—ovarian cancer	4.62e-06	0.000164	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NRAS—ovarian cancer	4.61e-06	0.000164	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	4.59e-06	0.000164	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HRAS—ovarian cancer	4.56e-06	0.000162	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	4.55e-06	0.000162	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	4.54e-06	0.000162	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.52e-06	0.000161	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MAPK3—ovarian cancer	4.51e-06	0.000161	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	4.44e-06	0.000158	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	4.41e-06	0.000157	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MYC—ovarian cancer	4.39e-06	0.000156	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL6—ovarian cancer	4.37e-06	0.000155	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	4.34e-06	0.000155	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MYC—ovarian cancer	4.32e-06	0.000154	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MYC—ovarian cancer	4.29e-06	0.000153	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MAPK1—ovarian cancer	4.29e-06	0.000153	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGFR—ovarian cancer	4.29e-06	0.000153	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MYC—ovarian cancer	4.23e-06	0.00015	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	4.22e-06	0.00015	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGFR—ovarian cancer	4.22e-06	0.00015	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	4.2e-06	0.00015	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGFR—ovarian cancer	4.2e-06	0.000149	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	4.13e-06	0.000147	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	4.13e-06	0.000147	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KRAS—ovarian cancer	4.05e-06	0.000144	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKT1—ovarian cancer	4.03e-06	0.000143	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KRAS—ovarian cancer	3.99e-06	0.000142	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KRAS—ovarian cancer	3.97e-06	0.000141	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTEN—ovarian cancer	3.91e-06	0.000139	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	3.9e-06	0.000139	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	3.72e-06	0.000133	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	3.66e-06	0.00013	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	3.64e-06	0.00013	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—ovarian cancer	3.6e-06	0.000128	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	3.59e-06	0.000128	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—ovarian cancer	3.54e-06	0.000126	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—ovarian cancer	3.52e-06	0.000126	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—ovarian cancer	3.47e-06	0.000124	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HRAS—ovarian cancer	3.44e-06	0.000123	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HRAS—ovarian cancer	3.39e-06	0.000121	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HRAS—ovarian cancer	3.37e-06	0.00012	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	3.32e-06	0.000118	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL6—ovarian cancer	3.3e-06	0.000117	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL6—ovarian cancer	3.24e-06	0.000116	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL6—ovarian cancer	3.23e-06	0.000115	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL6—ovarian cancer	3.18e-06	0.000113	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKT1—ovarian cancer	3.04e-06	0.000108	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKT1—ovarian cancer	2.99e-06	0.000107	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKT1—ovarian cancer	2.98e-06	0.000106	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	2.93e-06	0.000104	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.76e-06	9.81e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AKT1—ovarian cancer	2.25e-06	8.02e-05	CbGpPWpGaD
